• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

层次分析法和联合分析方法在评估中风康复治疗选择中的比较。

A comparison of analytic hierarchy process and conjoint analysis methods in assessing treatment alternatives for stroke rehabilitation.

机构信息

Department of Health Technology and Services Research, University of Twente, Enschede, the Netherlands.

出版信息

Patient. 2012;5(1):45-56. doi: 10.2165/11587140-000000000-00000.

DOI:10.2165/11587140-000000000-00000
PMID:22185216
Abstract

BACKGROUND

With growing emphasis on patient involvement in health technology assessment, there is a need for scientific methods that formally elicit patient preferences. Analytic hierarchy process (AHP) and conjoint analysis (CA) are two established scientific methods - albeit with very different objectives.

OBJECTIVE

The objective of this study was to compare the performance of AHP and CA in eliciting patient preferences for treatment alternatives for stroke rehabilitation.

METHODS

Five competing treatments for drop-foot impairment in stroke were identified. One survey, including the AHP and CA questions, was sent to 142 patients, resulting in 89 patients for final analysis (response rate 63%). Standard software was used to calculate attribute weights from both AHP and CA. Performance weights for the treatments were obtained from an expert panel using AHP. Subsequently, the mean predicted preference for each of the five treatments was calculated using the AHP and CA weights. Differences were tested using non-parametric tests. Furthermore, all treatments were rank ordered for each individual patient, using the AHP and CA weights.

RESULTS

Important attributes in both AHP and CA were the clinical outcome (0.3 in AHP and 0.33 in CA) and risk of complications (about 0.2 in both AHP and CA). Main differences between the methods were found for the attributes 'impact of treatment' (0.06 for AHP and 0.28 for two combined attributes in CA) and 'cosmetics and comfort' (0.28 for two combined attributes in AHP and 0.05 for CA). On a group level, the most preferred treatments were soft tissue surgery (STS) and orthopedic shoes (OS). However, STS was most preferred using AHP weights versus OS using CA weights (p < 0.001). This difference was even more obvious when interpreting the individual treatment ranks. Nearly all patients preferred STS according to the AHP predictions, while >50% of the patients chose OS instead of STS, as most preferred treatment using CA weights.

CONCLUSION

While we found differences between AHP and CA, these differences were most likely caused by the labeling of the attributes and the elicitation of performance judgments. CA scenarios are built using the level descriptions, and hence provide realistic treatment scenarios. In AHP, patients only compared less concrete attributes such as 'impact of treatment.' This led to less realistic choices, and thus overestimation of the preference for the surgical scenarios. Several recommendations are given on how to use AHP and CA in assessing patient preferences.

摘要

背景

随着越来越重视患者在卫生技术评估中的参与,需要有正式征求患者偏好的科学方法。层次分析法(AHP)和联合分析(CA)是两种已确立的科学方法-尽管目标非常不同。

目的

本研究旨在比较 AHP 和 CA 在诱发中风康复治疗替代方案患者偏好方面的性能。

方法

确定了 5 种用于治疗中风足下垂的竞争治疗方法。一项调查包括 AHP 和 CA 问题,共发送给 142 名患者,最终有 89 名患者进行了最终分析(应答率为 63%)。使用标准软件从 AHP 和 CA 中计算出属性权重。使用 AHP 从专家小组获得治疗方法的绩效权重。随后,使用 AHP 和 CA 权重计算出五种治疗方法的平均预测偏好。使用非参数检验检验差异。此外,使用 AHP 和 CA 权重,对每个个体患者对所有治疗方法进行了排序。

结果

AHP 和 CA 中的重要属性均为临床结果(AHP 中为 0.3,CA 中为 0.33)和并发症风险(AHP 和 CA 中均约为 0.2)。两种方法之间的主要区别在于“治疗效果”(AHP 中为 0.06,CA 中为两个综合属性的 0.28)和“美容和舒适”(AHP 中为两个综合属性的 0.28,CA 中为 0.05)。在组水平上,最受欢迎的治疗方法是软组织手术(STS)和矫形鞋(OS)。但是,根据 AHP 权重,STS 是最受欢迎的治疗方法,而根据 CA 权重,OS 是最受欢迎的治疗方法(p <0.001)。当解释个别治疗排名时,这种差异更为明显。几乎所有患者根据 AHP 预测都更喜欢 STS,而> 50%的患者选择 OS 而不是 STS,因为这是 CA 权重下最受欢迎的治疗方法。

结论

尽管我们发现 AHP 和 CA 之间存在差异,但这些差异很可能是由于属性的标记和绩效判断的启发引起的。CA 场景是使用级别描述构建的,因此提供了现实的治疗场景。在 AHP 中,患者仅比较不太具体的属性,例如“治疗效果”。这导致了不太现实的选择,从而高估了对手术场景的偏好。就如何使用 AHP 和 CA 评估患者偏好提出了一些建议。

相似文献

1
A comparison of analytic hierarchy process and conjoint analysis methods in assessing treatment alternatives for stroke rehabilitation.层次分析法和联合分析方法在评估中风康复治疗选择中的比较。
Patient. 2012;5(1):45-56. doi: 10.2165/11587140-000000000-00000.
2
Comparing Analytic Hierarchy Process and Discrete-Choice Experiment to Elicit Patient Preferences for Treatment Characteristics in Age-Related Macular Degeneration.比较层次分析法和离散选择实验以引出年龄相关性黄斑变性患者对治疗特征的偏好。
Value Health. 2017 Sep;20(8):1166-1173. doi: 10.1016/j.jval.2017.04.022. Epub 2017 May 31.
3
Comparison of two multi-criteria decision techniques for eliciting treatment preferences in people with neurological disorders.比较两种多准则决策技术在神经障碍患者中诱发治疗偏好的效果。
Patient. 2008 Dec 1;1(4):265-72. doi: 10.2165/1312067-200801040-00008.
4
Integrating patients' views into health technology assessment: Analytic hierarchy process (AHP) as a method to elicit patient preferences.将患者观点纳入卫生技术评估:层次分析法(AHP)作为一种 eliciting 患者偏好的方法。
Int J Technol Assess Health Care. 2011 Oct;27(4):369-75. doi: 10.1017/S0266462311000523.
5
Do They Align? Congruence Between Patient Preferences of People Living with Cognitive Impairments and Physicians' Judgements for Person-Centered Care: An Analytic Hierarchy Process Study.他们一致吗?认知障碍患者的偏好与医生的判断对于以患者为中心的护理的一致性:一项层次分析法研究。
J Alzheimers Dis. 2023;91(2):727-741. doi: 10.3233/JAD-220753.
6
Using the analytic hierarchy process to elicit patient preferences: prioritizing multiple outcome measures of antidepressant drug treatment.运用层次分析法获取患者偏好:对多种抗抑郁药物治疗结果指标进行优先级排序。
Patient. 2012;5(4):225-37. doi: 10.1007/BF03262495.
7
How Well Can Analytic Hierarchy Process be Used to Elicit Individual Preferences? Insights from a Survey in Patients Suffering from Age-Related Macular Degeneration.层次分析法在引出个体偏好方面的效果如何?来自年龄相关性黄斑变性患者调查的见解。
Patient. 2016 Oct;9(5):481-92. doi: 10.1007/s40271-016-0179-7.
8
Using an analytical hierarchy process (AHP) for weighting items of a measurement scale: a pilot study.使用层次分析法(AHP)对测量量表项目进行加权:一项初步研究。
Rev Epidemiol Sante Publique. 2010 Feb;58(1):59-63. doi: 10.1016/j.respe.2009.09.004. Epub 2010 Jan 21.
9
The use of the analytic hierarchy process to aid decision making in acquired equinovarus deformity.运用层次分析法辅助获得性马蹄内翻畸形的决策制定。
Arch Phys Med Rehabil. 2008 Mar;89(3):457-62. doi: 10.1016/j.apmr.2007.09.030.
10
[Patients' Priorities in the Treatment of Neuroendocrine Tumours: An Analytical Hierarchy Process].[神经内分泌肿瘤治疗中患者的优先事项:层次分析法]
Gesundheitswesen. 2016 Oct;78(10):651-657. doi: 10.1055/s-0035-1548932. Epub 2015 Jun 25.

引用本文的文献

1
Evaluation of hospital disaster preparedness by a multi-criteria decision making approach: The case of Turkish hospitals.采用多标准决策方法评估医院灾难准备情况:以土耳其医院为例。
Int J Disaster Risk Reduct. 2020 Oct;49:101748. doi: 10.1016/j.ijdrr.2020.101748. Epub 2020 Jul 5.
2
Feasibility of Measuring Preferences for Chemotherapy Among Early-Stage Breast Cancer Survivors Using a Direct Rank Ordering Multicriteria Decision Analysis Versus a Time Trade-Off.采用直接排序多准则决策分析与时间权衡法测量早期乳腺癌幸存者对化疗偏好的可行性。
Patient. 2020 Oct;13(5):557-566. doi: 10.1007/s40271-020-00423-w.
3
Assessment and prioritization of the WHO "best buys" and other recommended interventions for the prevention and control of non-communicable diseases in Iran.

本文引用的文献

1
Comparison of two multi-criteria decision techniques for eliciting treatment preferences in people with neurological disorders.比较两种多准则决策技术在神经障碍患者中诱发治疗偏好的效果。
Patient. 2008 Dec 1;1(4):265-72. doi: 10.2165/1312067-200801040-00008.
2
The use of multi-criteria decision analysis weight elicitation techniques in patients with mild cognitive impairment: a pilot study.多准则决策分析权重 elicitation 技术在轻度认知障碍患者中的应用:一项初步研究。
Patient. 2008 Apr 1;1(2):127-35. doi: 10.2165/01312067-200801020-00008.
3
Multi-criteria clinical decision support: A primer on the use of multiple criteria decision making methods to promote evidence-based, patient-centered healthcare.
对伊朗预防和控制非传染性疾病的世界卫生组织“最佳采购”及其他推荐干预措施的评估与优先排序。
BMC Public Health. 2020 Mar 14;20(1):333. doi: 10.1186/s12889-020-8446-x.
4
What attributes should be included in a discrete choice experiment related to health technologies? A systematic literature review.与健康技术相关的离散选择实验应包含哪些属性?系统文献回顾。
PLoS One. 2019 Jul 18;14(7):e0219905. doi: 10.1371/journal.pone.0219905. eCollection 2019.
5
Desiderata for sharable computable biomedical knowledge for learning health systems.学习型健康系统中可共享、可计算生物医学知识的必备条件。
Learn Health Syst. 2018 Aug 3;2(4):e10065. doi: 10.1002/lrh2.10065. eCollection 2018 Oct.
6
Assessing the Importance of Treatment Goals in Patients with Psoriasis: Analytic Hierarchy Process vs. Likert Scales.评估银屑病患者治疗目标的重要性:层次分析法与李克特量表。
Patient. 2018 Aug;11(4):425-437. doi: 10.1007/s40271-018-0300-1.
7
Preferences of psychiatric practitioners for core symptoms of major depressive disorder: a hidden conjoint analysis.精神科医生对重度抑郁症核心症状的偏好:一项隐性联合分析
Int J Methods Psychiatr Res. 2017 Mar;26(1). doi: 10.1002/mpr.1528. Epub 2016 Nov 9.
8
Measuring patients' priorities using the Analytic Hierarchy Process in comparison with Best-Worst-Scaling and rating cards: methodological aspects and ranking tasks.与最佳-最差比例法和评分卡相比,使用层次分析法衡量患者的优先事项:方法学方面和排序任务
Health Econ Rev. 2016 Dec;6(1):50. doi: 10.1186/s13561-016-0130-6. Epub 2016 Nov 14.
9
How Well Can Analytic Hierarchy Process be Used to Elicit Individual Preferences? Insights from a Survey in Patients Suffering from Age-Related Macular Degeneration.层次分析法在引出个体偏好方面的效果如何?来自年龄相关性黄斑变性患者调查的见解。
Patient. 2016 Oct;9(5):481-92. doi: 10.1007/s40271-016-0179-7.
10
The value of quantitative patient preferences in regulatory benefit-risk assessment.定量患者偏好信息在监管效益风险评估中的价值
J Mark Access Health Policy. 2014 Apr 1;2. doi: 10.3402/jmahp.v2.22761. eCollection 2014.
多标准临床决策支持:关于使用多标准决策方法促进循证、以患者为中心的医疗保健的入门指南。
Patient. 2010;3(4):229-248. doi: 10.2165/11539470-000000000-00000.
4
Application of the BRAT framework to case studies: observations and insights.BRAT 框架在案例研究中的应用:观察与见解。
Clin Pharmacol Ther. 2011 Feb;89(2):217-24. doi: 10.1038/clpt.2010.280. Epub 2010 Dec 22.
5
Patients' perspectives in health technology assessment: a route to robust evidence and fair deliberation.患者在健康技术评估中的观点:获得稳健证据和公平审议的途径。
Int J Technol Assess Health Care. 2010 Jul;26(3):334-40. doi: 10.1017/S0266462310000395.
6
International experience with comparative effectiveness research: case studies from England/Wales and Germany.比较效果研究的国际经验:来自英格兰/威尔士和德国的案例研究
Adv Health Econ Health Serv Res. 2010;22:29-50. doi: 10.1108/s0731-2199(2010)0000022005.
7
The efficiency frontier approach to economic evaluation of health-care interventions.效率边界方法在医疗干预经济评估中的应用。
Health Econ. 2010 Oct;19(10):1117-27. doi: 10.1002/hec.1629.
8
Defining comparative effectiveness research: the importance of getting it right.定义比较效果研究:正确定义的重要性。
Med Care. 2010 Jun;48(6 Suppl):S7-8. doi: 10.1097/MLR.0b013e3181da3709.
9
A review of quantitative risk-benefit methodologies for assessing drug safety and efficacy-report of the ISPOR risk-benefit management working group.评估药物安全性和疗效的定量风险效益方法学综述——ISPOR 风险效益管理工作组的报告。
Value Health. 2010 Aug;13(5):657-66. doi: 10.1111/j.1524-4733.2010.00725.x. Epub 2010 Apr 15.
10
A distorted picture of IQWiG methodology.对IQWiG方法的歪曲描述。
Health Aff (Millwood). 2010 Jan-Feb;29(1):220-1; author reply 221. doi: 10.1377/hlthaff.2009.0980.